Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
Randomized, double-blind, placebo-controlled, 16-week study designed to explore the safety and efficacy of IMC-1 for the treatment of patients with fibromyalgia.
Epistemonikos ID: ac45c53454e007cac1eac4f9c1873e26626bda28
First added on: May 08, 2024